Featured Research

from universities, journals, and other organizations

Does baseline concussion testing really reduce risks to athletes?

Date:
June 1, 2011
Source:
Loyola University Health System
Summary:
Baseline concussion tests given to hundreds of thousands of athletes might, paradoxically, increase risks in some cases, according to new research.

Baseline concussion tests given to hundreds of thousands of athletes might, paradoxically, increase risks in some cases, according to a Loyola University Health System researcher.

The tests are likely to have a high "false negative" rate, meaning a test shows an athlete has recovered, when in fact he or she is still experiencing cognitive impairments from the concussion.

This could increase risks by returning to play athletes who might otherwise be withheld for a longer period, neuropsychologist Christopher Randolph, PhD, writes in a recent issue of the journal Current Sports Medicine Reports.

Baseline concussion testing is mandatory in many football, hockey and other programs, from elementary schools to the pros. Such testing provides a baseline score of an athlete's attention span, working memory, reaction time, etc. If the athlete suffers a concussion, he or she retakes the test. If there is a large decrease in the post-concussion score, the athlete typically is benched until the score increases.

Randolph examined the most common baseline test, called ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing). The 20-minute test is taken on a computer.

"There is no evidence to suggest that the use of baseline testing alters any risk from sport-related concussion, nor is there even a good rationale as to how such tests might influence outcome," Randolph writes.

In searching the scientific literature, Randolph could not find a single prospective, controlled study of the current version of ImPACT (version 2.0). Such a study would involve baseline testing a large sample of athletes and then retesting concussive athletes in comparison with noninjured teammates. There was a single prospective, controlled study of an earlier version (1.0), but that study had several serious flaws, Randolph writes.

Studies by independent researchers have found that the reliability of ImPACT testing "appears to be far too low to be useful for individual decision making," Randolph writes.

Using baseline testing with poor sensitivity and inadequate reliability could create a false sense of security that an athlete has recovered from a concussion.

Rather than relying on ImPACT or other baseline tests, team medical personnel "may be better advised to rely upon their own clinical judgment, in conjunction with a validated symptom checklist, in making return-to-play decisions," Randolph writes.

Randolph is a professor in the Department of Neurology at Loyola University Chicago Stritch School of Medicine.


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Journal Reference:

  1. Randolph, Christopher. Baseline Neuropsychological Testing in Managing Sport-Related Concussion: Does It Modify Risk? Current Sports Medicine Reports, 10(1):21-26, January/February 2011 DOI: 10.1249/JSR.0b013e318207831d

Cite This Page:

Loyola University Health System. "Does baseline concussion testing really reduce risks to athletes?." ScienceDaily. ScienceDaily, 1 June 2011. <www.sciencedaily.com/releases/2011/06/110601142052.htm>.
Loyola University Health System. (2011, June 1). Does baseline concussion testing really reduce risks to athletes?. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/06/110601142052.htm
Loyola University Health System. "Does baseline concussion testing really reduce risks to athletes?." ScienceDaily. www.sciencedaily.com/releases/2011/06/110601142052.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins